Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Malignant Melanoma

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 46 articles:
HTML format



Single Articles


    May 2008
  1. BOISVERT-ADAMO K , Aplin AE
    Mutant B-RAF mediates resistance to anoikis via Bad and Bim.
    Oncogene. 2008;27:3301-12.
    PubMed     Related articles    Abstract available


  2. ELCHEVA I , Tarapore RS, Bhatia N, Spiegelman VS, et al
    Overexpression of mRNA-binding protein CRD-BP in malignant melanomas.
    Oncogene. 2008;.
    PubMed     Related articles    Abstract available


  3. BANERJEE T , Duhadaway JB, Gaspari P, Sutanto-Ward E, et al
    A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
    Oncogene. 2008;27:2851-7.
    PubMed     Related articles    Abstract available


    April 2008
  4. HASSAN M , Alaoui A, Feyen O, Mirmohammadsadegh A, et al
    The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways.
    Oncogene. 2008;.
    PubMed     Related articles    Abstract available


    February 2008
  5. DAVIS E , Teng H, Bilican B, Parker MI, et al
    Ectopic Tbx2 expression results in polyploidy and cisplatin resistance.
    Oncogene. 2008;27:976-84.
    PubMed     Related articles    Abstract available


    January 2008
  6. KRAMER OH , Knauer SK, Zimmermann D, Stauber RH, et al
    Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis.
    Oncogene. 2008;27:732-40.
    PubMed     Related articles    Abstract available


  7. GURZOV EN , Bakiri L, Alfaro JM, Wagner EF, et al
    Targeting c-Jun and JunB proteins as potential anticancer cell therapy.
    Oncogene. 2008;27:641-52.
    PubMed     Related articles    Abstract available


    December 2007
  8. GESERICK P , Drewniok C, Hupe M, Haas TL, et al
    Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available


  9. CUI Y , Guadagno TM
    B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available


    October 2007
  10. FUKUNAGA-KALABIS M , Martinez G, Telson SM, Liu ZJ, et al
    Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available


  11. MANTOVANI G , Bondioni S, Lania AG, Rodolfo M, et al
    High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available


    September 2007
  12. KAUFFMANN A , Rosselli F, Lazar V, Winnepenninckx V, et al
    High expression of DNA repair pathways is associated with metastasis in melanoma patients.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available


  13. LI Y , Huang J, Zhao YL, He J, et al
    UTRN on chromosome 6q24 is mutated in multiple tumors.
    Oncogene. 2007;26:6220-8.
    PubMed     Related articles    Abstract available


    August 2007
  14. KUSTERS B , Kats G, Roodink I, Verrijp K, et al
    Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis.
    Oncogene. 2007;26:5808-15.
    PubMed     Related articles    Abstract available


    July 2007
  15. BAE SI , Cheriyath V, Jacobs BS, Reu FJ, et al
    Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available


  16. WHITWAM T , Vanbrocklin MW, Russo ME, Haak PT, et al
    Differential oncogenic potential of activated RAS isoforms in melanocytes.
    Oncogene. 2007;26:4563-70.
    PubMed     Related articles    Abstract available


    June 2007
  17. ORICCHIO E , Sciamanna I, Beraldi R, Tolstonog GV, et al
    Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression.
    Oncogene. 2007;26:4226-33.
    PubMed     Related articles    Abstract available


    April 2007
  18. SURYO RAHMANTO Y , Dunn LL, Richardson DR
    The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark - from iron metabolism to tumorigenesis.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available


  19. HUANG W , Chang HY, Fei T, Wu H, et al
    GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN.
    Oncogene. 2007;26:2471-82.
    PubMed     Related articles    Abstract available


    February 2007
  20. HAMAI A , Richon C, Meslin F, Faure F, et al
    Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation.
    Oncogene. 2007;26:1256.
    PubMed     Related articles   


  21. MOSCHOS SJ , Smith AP, Mandic M, Athanassiou C, et al
    SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available


    January 2007
  22. JONSSON G , Dahl C, Staaf J, Sandberg T, et al
    Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available


  23. AMERI K , Hammond EM, Culmsee C, Raida M, et al
    Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway.
    Oncogene. 2007;26:284-9.
    PubMed     Related articles    Abstract available


    December 2006
  24. LI B , Smith CC, Laing JM, Gober MD, et al
    Overload of the heat-shock protein H11/HspB8 triggers melanoma cell apoptosis through activation of transforming growth factor-beta-activated kinase 1.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  25. ROTHHAMMER T , Bataille F, Spruss T, Eissner G, et al
    Functional implication of BMP4 expression on angiogenesis in malignant melanoma.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  26. KURBANOV BM , Fecker LF, Geilen CC, Sterry W, et al
    Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  27. LEOTLELA PD , Wade MS, Duray PH, Rhode MJ, et al
    Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


    November 2006
  28. DEL BELLO B , Moretti D, Gamberucci A, Maellaro E, et al
    Cross-talk between calpain and caspase-3/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of calpain inhibition in cell death protection and p53 status.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  29. SHIELDS JD , Emmett MS, Dunn DB, Joory KD, et al
    Chemokine-mediated migration of melanoma cells towards lymphatics - a mechanism contributing to metastasis.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


    September 2006
  30. LIU J , Suresh Kumar KG, Yu D, Molton SA, et al
    Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  31. HAMAI A , Richon C, Meslin F, Faure F, et al
    Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  32. MITCHELL DC , Stafford LJ, Li D, Bar-Eli M, et al
    Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  33. REITER F , Hartl M, Karagiannidis AI, Bister K, et al
    WS5, a direct target of oncogenic transcription factor Myc, is related to human melanoma glycoprotein genes and has oncogenic potential.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


    August 2006
  34. BHATT KV , Hu R, Spofford LS, Aplin AE, et al
    Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27(Kip1) in human melanoma cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  35. SHI J , Kahle A, Hershey JW, Honchak BM, et al
    Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells.
    Oncogene. 2006;25:4923-36.
    PubMed     Related articles    Abstract available


  36. LACREUSETTE A , Nguyen JM, Pandolfino MC, Khammari A, et al
    Loss of oncostatin M receptor beta in metastatic melanoma cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  37. COHEN Z , Bacharach E, Lavi S
    Mouse major satellite DNA is prone to eccDNA formation via DNA Ligase IV-dependent pathway.
    Oncogene. 2006;25:4515-24.
    PubMed     Related articles    Abstract available


    July 2006
  38. SHIRAISHI K , Yamasaki K, Nanba D, Inoue H, et al
    Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


    June 2006
  39. AMIRI KI , Ha HC, Smulson ME, Richmond A, et al
    Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  40. FERRARO D , Corso S, Fasano E, Panieri E, et al
    Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS).
    Oncogene. 2006;25:3689-98.
    PubMed     Related articles    Abstract available


    May 2006
  41. YEH AH , Bohula EA, Macaulay VM
    Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  42. TAKEUCHI T , Adachi Y, Sonobe H, Furihata M, et al
    A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  43. CRUZ-MUNOZ W , Sanchez OH, Di Grappa M, English JL, et al
    Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3(-/-) mice.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  44. YAN H , Thomas J, Liu T, Raj D, et al
    Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


    March 2006
  45. KUPHAL S , Lodermeyer S, Bataille F, Schuierer M, et al
    Expression of Dickkopf genes is strongly reduced in malignant melanoma.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


  46. BOISVERT-ADAMO K , Aplin AE
    B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: